Huatangning, the world's first new hypoglycemic drug was approved
2022-10-09
Beijing, Oct. 9, 2022 -- Bayer announced that the global initiative for state and drug administration approved the diabetes drug ITO ning (Glenn YiTing), used alone, or in a separate use of metformin hydrochloride poor blood sugar control, and used in combination with metformin hydrochloride, cooperate with diet and exercise to improve glycemic control in adults with type 2 diabetes. Huatangning is a product cooperation between Bayer and Hualing Medicine in the field of diabetes treatment. It's the first glucokinase activator drug approved in the world.
